News
This article was first released to Systematic Income subscribers and free trials on June 25. Welcome to another installment of our CEF Market Weekly...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Full time trader and investor. Instead of lengthy and boring articles, I prefer writing concise arguments about value...
News
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
News
Driven Brands Holdings Inc. (NASDAQ:DRVN) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Joel Arnao – Senior Vice President...
News
There’s little question that online, robocall and other call scams are highly organized and often run by overseas crime operations. They typically prey on...
News
Author’s Note: This article is part of our periodic/monthly series that attempts to present three lists of stocks for the month that could be...
News
(Note: This article was in the newsletter on June 24, 2023.) Exxon Mobil Corporation (NYSE:XOM) management appears to be adding to what many would...
News
I think it’s worth reiterating what I wrote about in my article Undervalued Dividend Stocks Watchlist – What Goes Up Must Come Down where...
News
The Revival Of The Metaverse Investment Thesis We previously covered Walt Disney Company (NYSE:DIS) in May 2023, covering its mixed FQ2’23 performance then. The...
News
Introduction Although I definitely prioritize owning cumulative preferred shares, I have to acknowledge that in some cases I wouldn’t mind adding a non-cumulative preferred...
News
Investment Thesis Dividend payments can be an excellent source of additional income for investors, particularly when the selected companies not only provide Dividend Income,...
News
The CVS Investment Thesis Looks More Attractive After The Steep Sell-Off We previously covered CVS Health (NYSE:CVS) in January 2023, suggesting the dangers of...
News
The WBA Investment Thesis Remains Robust Here We previously covered Walgreens Boots (NASDAQ:WBA) in February 2023, suggesting that the stock was a great buy...
